Prevalence of EGFR mutations in patients with resected stage I-III non-squamous NSCLC: Results from the EARLY-EGFR study.
dc.contributor.author | Soo, Ross A. | |
dc.contributor.author | Reungwetwattana, Thanyanan | |
dc.contributor.author | Perroud, Herman Andres | |
dc.contributor.author | Batra, Ullas | |
dc.contributor.author | Kilickap, Saadettin | |
dc.contributor.author | Gallegos, Luis Fernando Tejado | |
dc.contributor.author | Donner, Natalia | |
dc.date.accessioned | 2024-05-19T14:51:33Z | |
dc.date.available | 2024-05-19T14:51:33Z | |
dc.date.issued | 2023 | |
dc.department | İstinye Üniversitesi | en_US |
dc.description | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 02-06, 2023 -- Chicago, IL | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.description.sponsorship | AstraZeneca | en_US |
dc.description.sponsorship | AstraZeneca. | en_US |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 16 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/5969 | |
dc.identifier.volume | 41 | en_US |
dc.identifier.wos | WOS:001053772003607 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | 20240519_ka | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | Prevalence of EGFR mutations in patients with resected stage I-III non-squamous NSCLC: Results from the EARLY-EGFR study. | en_US |
dc.type | Conference Object | en_US |